CMS releases ICD-10 codes for new COVID-19 therapies
The Centers for Medicare & Medicaid Services today added 12 new ICD-10 procedure codes to identify new therapies for COVID-19.
These include remdesivir and convalescent plasma, as well as any future COVID-19 therapeutic that does not have a unique name.
CMS also released a new ICD-10 Medicare Severity-Diagnosis Related Group Grouper software package (Version 37.2) to accommodate the new codes, effective for discharges on or after Aug. 1.
The new codes will not affect the MS-DRG assignment.
Related News Articles
Headline
CDC issues reminder on ending of the emergency authorization for COVID-19 in vitro diagnostics tests
The Centers for Disease Control and Prevention issued a reminder Oct. 14 that the declaration supporting the emergency use of COVID-19 in vitro diagnostics…
Headline
An AHA blog published Oct. 5 responds to a Blue Cross Blue Shield Association report suggesting that hospitals’ use of artificial intelligence-enabled…
Headline
The Department of Health of Human Services Aug. 21 issued a request for information seeking feedback on immunization categories within the Aug. 10 executive…
Headline
For the 2025-2026 school year, exemptions from one or more vaccines among U.S. kindergartners was at 4.2%, increasing from 3.6% for the previous school year,…
Headline
A study published Aug. 5 by Nature found that COVID-19 infection can reactivate dormant, chronic viruses such as Epstein-Barr and cytomegalovirus. The study…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…